F13.282
Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F13.282 describes a condition where an individual becomes dependent on sedatives, hypnotics, or anxiolytics—medications commonly used to manage anxiety, sleep disturbances, or both—and experiences a sleep disorder induced by these drugs. This condition highlights issues related to medication dependence and its associated impact on sleep health, often requiring careful management and treatment.
Causes & Symptoms
Clinical Causes: Long-term use of sedative, hypnotic, or anxiolytic medications prescribed for sleep or anxiety problems Development of tolerance, leading to increased dosage over time Psychological factors such as ongoing anxiety or stress that lead to continued use of these medications Lack of proper medication oversight or abrupt discontinuation of therapy Pre-existing sleep or mental health disorders that contribute to medication dependence
Key Symptoms: Craving or a strong desire to continue using sedatives, hypnotics, or anxiolytics Inability to reduce or stop medication use despite negative effects Experiencing withdrawal symptoms when not taking the medication Persistent sleep disturbances despite medication use Feeling anxious, irritable, or restless without the medication Sleep that may be light, fragmented, or non-restorative Daytime drowsiness or fatigue related to sleep issues
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a comprehensive medical and psychological evaluation, including reviewing medication history, assessing dependency signs, and examining sleep patterns. Healthcare providers may use standardized assessment tools to determine the severity of dependence and sleep disturbances. Sleep studies may also be recommended to evaluate sleep quality and patterns, especially if sleep disorders persist independently of medication use.
Treatment Protocols: Managing this condition involves multiple approaches tailored to the individual's needs. Treatment options include: - **Medication review and tapering:** Gradual discontinuation or substitution under medical supervision to minimize withdrawal symptoms. - **Cognitive-behavioral therapy (CBT):** Particularly CBT for insomnia (CBT-I), to improve sleep hygiene and address underlying psychological factors. - **Addressing mental health issues:** Treating underlying anxiety or mood disorders that contribute to medication dependence. - **Support groups and counseling:** To provide psychological support and develop healthier coping strategies. - **Lifestyle modifications:** Emphasizing regular sleep schedules, reducing caffeine and alcohol, and creating a restful sleeping environment. Implementing these strategies involves close collaboration with healthcare professionals to ensure safe and effective management.
Clinical Advice & FAQs
Billing Guidance
Is F13.282 a billable ICD-10 code?
Yes, F13.282 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.282?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sleep disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference